Mode
Text Size
Log in / Sign up

FDA approved Paragard T 380A (copper IUS) for Prevention of Pregnancy for Up to 10 YearsFDA approved copper birth control device that prevents pregnancy for up to 10 years

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Paragard is approved for up to 10 years of pregnancy prevention and must be inserted by a trained provider.

The U.S. Food and Drug Administration has approved Paragard T 380A, a copper-containing intrauterine system (IUS), for the prevention of pregnancy in females of reproductive potential for up to 10 years. The approval provides clinicians with a long-acting, non-hormonal contraceptive option that can be inserted at any time during the menstrual cycle, including immediately postpartum or postabortion, though expulsion risk may be higher in certain settings.

Paragard must be inserted at the fundus of the uterine cavity by a healthcare provider trained in the device's specific insertion procedure, which differs from that of other intrauterine systems. The label emphasizes proper patient selection, exclusion of pregnancy before insertion, and confirmation of correct placement after the first menses. Removal is required no later than 10 years from insertion, and replacement with a new device may be performed at the time of removal if continued contraception is desired. Clinical trial data are not available in the label.

+ Clinical Details (Mechanism · Dosing · Trial Data · Warnings)
Mechanism of Action

Not reported in label.

Indication & Patient Population

Paragard is indicated for prevention of pregnancy in females of reproductive potential for up to 10 years. It is a copper-containing intrauterine system (IUS).

Dosing & Administration

Insert a single Paragard at the fundus of the uterine cavity. Remove Paragard no later than 10 years from the date of insertion. Insert and remove only if you are a healthcare provider trained on these procedures. Following insertion, examine the patient after her first menses to confirm Paragard is still in place. Paragard should only be inserted by a healthcare provider trained in Paragard's insertion procedures, because insertion for Paragard is different from that used for other intrauterine systems. Healthcare providers should become thoroughly familiar with the product, product educational materials, product insertion instructions, and prescribing information before attempting insertion. May replace Paragard at the time of removal with a new Paragard if continued contraceptive protection is desired. Before considering use, make sure that the female is an appropriate candidate and exclude pregnancy prior to use. Recommended timing of insertion: in females not currently using contraception, at any time during the menstrual cycle; when switching from an oral, transdermal, or vaginal hormonal contraceptive or an injectable progestin, at any time during the menstrual cycle and discontinue the previous method; when switching from a contraceptive implant or other intrauterine system, on the same day the implant or IUS is removed (insert at any time during the menstrual cycle); after abortion or miscarriage, immediately after abortion (immediate placement has a slightly higher risk of expulsion than placement at other times; insertion after second trimester abortion is associated with a higher risk of expulsion than after first trimester abortion); after childbirth, may insert immediately postpartum (insertion before uterine involution is complete, which may not occur until the second postpartum month, has been associated with increased risk of expulsion; there appears to be an increased risk of perforation in lactating women). For immediate insertion post childbirth, remove the inserter and Paragard from the tray, move the button forward and then completely back to release the Paragard unit from the inserter and insert Paragard. Preparation: use strict aseptic techniques; prepare placement tools; consider use of an analgesic; establish size and position of uterus by bi-manual examination; insert speculum and cleanse cervix and vagina with antiseptic solution; apply tenaculum and use gentle traction; gently insert a sterile uterine sound to measure depth (uterus should sound to 6 to 9 cm except when inserting immediately postabortion or postpartum). Insertion may be associated with pain and/or bleeding, vasovagal reactions, or seizure, especially in patients with a predisposition. Insertion into a uterine cavity measuring less than 6 cm may increase the incidence of expulsion, bleeding, pain, and perforation. If cervical stenosis is encountered, avoid undue force; dilators and analgesia/local anesthesia may be helpful.

Key Clinical Trial Data

Trial data not available in label.

Warnings & Contraindications

Not reported in label.

Place in Therapy

Not reported in label.

Paragard T 380A is a small, copper-containing device that a healthcare provider places inside the uterus to prevent pregnancy. The FDA approved it for people who can become pregnant, and it works for up to 10 years. It is non-hormonal, which may appeal to people who prefer not to use hormones.

The device can be inserted at any point in the menstrual cycle, including right after childbirth or after an abortion. A trained provider must place it in a specific spot in the uterus and check that it is in the right position after the first period. It must be removed by 10 years, and a new one can be placed at that time if continued birth control is wanted.

This approval adds a long-acting option to the choices available. It does not mean the device suits everyone. Some people may have a higher chance of the device coming out, and pregnancy must be ruled out before insertion.

If you are thinking about birth control, talk with your doctor or a healthcare provider. They can help you weigh the benefits and risks and decide what fits your health and your life.

What this means for you:
A new 10-year copper birth control device is approved. Ask your doctor if it fits your needs.

Study Details

Study typeFda approval
PublishedNov 1984
View Original Abstract ↓
1 INDICATIONS AND USAGE Paragard is indicated for prevention of pregnancy in females of reproductive potential for up to 10 years. Paragard is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 10 years. ( 1 )
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.